NAHDI MEDICAL COMPANY |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 135.8 SAR | -0.15% |
|
-3.14% | -0.88% |
| Mar. 18 | Nahdi Medical Company Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 18 | Nahdi Medical Posts Higher FY23 Net Profit, Revenue | MT |
| Sales 2024 * | 9.11B 2.43B | Sales 2025 * | 9.57B 2.55B | Capitalization | 17.65B 4.71B |
|---|---|---|---|---|---|
| Net income 2024 * | 893M 238M | Net income 2025 * | 961M 256M | EV / Sales 2024 * | 1.97 x |
| Net Debt 2024 * | 269M 71.85M | Net Debt 2025 * | 142M 37.86M | EV / Sales 2025 * | 1.86 x |
| P/E ratio 2024 * |
19.8
x | P/E ratio 2025 * |
18.4
x | Employees | 6,182 |
| Yield 2024 * |
3.98% | Yield 2025 * |
4.36% | Free-Float | 40% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.15% | ||
| 1 week | -3.14% | ||
| Current month | -7.62% | ||
| 1 month | -11.36% | ||
| 3 months | -5.56% | ||
| 6 months | -2.30% | ||
| Current year | -0.88% |
1 week
134.60
142.60
1 month
134.60152.00
Current year
134.60156.80
1 year
129.00183.40
3 years
129.00209.40
5 years
129.00209.40
10 years
129.00209.40
| Managers | Title | Age | Since |
|---|---|---|---|
Yasser Joharji
CEO | Chief Executive Officer | 53 | 13-12-31 |
| Founder | 62 | 86-06-17 | |
| Director of Finance/CFO | 50 | 12-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 20-12-31 | |
| Director/Board Member | 71 | 20-12-31 | |
Junaid Bajwa
BRD | Director/Board Member | 45 | 20-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.16% | 3 M€ | -.--% | - | |
| 0.16% | 1 M€ | +3.49% | - | |
| 0.03% | 2,808 M€ | +5.90% | - | |
| 0.03% | 441 M€ | +4.60% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 135.8 | -0.15% | 322,264 |
| 24-04-24 | 136 | -0.73% | 335,274 |
| 24-04-23 | 137 | -2.14% | 357,868 |
| 24-04-22 | 140 | -1.27% | 355,879 |
| 24-04-21 | 141.8 | +1.14% | 261,096 |
End-of-day quote Saudi Arabian S.E., April 24, 2024
More quotes
Al Nahdi Medical Company SJSC is a Saudi Arabia-based retail pharmacy and healthcare company. The Company is engaged in the wholesale and retail trading of cosmetics, pharmaceutical products, special and healthy foods and medical equipment. The Company operates two operating segments: Front Shop and Pharma. The Company provides medicine, wellness, mom & baby, beauty and other wide-ranging FMCG products. The Company provides omni-health services through its polyclinics, express clinics, telemedicine, labs, and home healthcare. The Company operates approximately 1,150 stores in 144 cities and towns in the Kingdom of Saudi Arabia and the United Arab Emirates. The Companyâs subsidiaries include Al Nahdi Care, Sakhaa Golden Company, and Nahdi Investment Company.
Sector
Drug Retailers
Calendar
2024-05-13
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
D-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
135.8
SAR
Average target price
155.4
SAR
Spread / Average Target
+14.46%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -0.88% | 4.71B | |
| -31.97% | 10.84B | |
| +8.14% | 6.04B | |
| -11.41% | 5.86B | |
| -30.42% | 6.06B | |
| +52.19% | 4.29B | |
| -12.31% | 3.61B | |
| -14.86% | 3.33B | |
| -6.93% | 3.01B | |
| -1.22% | 2.8B |
- Stock Market
- Equities
- 4164 Stock
